For questions about financial assistance,1-844-DUPIXENT, option 1 or
click to learn more
What could your child DU With Less Asthma? See the results to learn how DUPIXENT helped.
DUPIXENT was proven to improve lung function and help prevent
asthma attacks in children 6-11 years.
DUPIXENT is not a steroid but
can help reduce oral steroid use.
DUPIXENT was studied in a clinical trial with 408 children 6 to 11 years old with persistent moderate-to-severe asthma.*
*In those with high eosinophil counts (a type of white blood cell).
†The annual rate of severe asthma attacks was 0.24 with DUPIXENT 200 MG vs 0.67 with placebo.
‡Do not stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.
The safety results of DUPIXENT observed in children through week 52 were similar to the safety profile from studies in adults and adolescents with moderate-to-severe asthma with the addition of parasitic (helminth) infections.
The most common side effects include:
View the possible side effects of DUPIXENT in patients with moderate-to-severe
eosinophilic or oral corticosteroid dependent asthma.
After talking with our asthma doctor, we started to feel more
comfortable with the idea of trying something different … In our
opinion, it was the best decision we have made for Aston.
Christan,
Caregiver of Aston
Aston, real patient. Individual results may vary.
Need help discussing DUPIXENT with your loved one’s doctor?
Take advantage of our doctor discussion guide to help.
Sign up to receive exclusive DUPIXENT emails and resources,
providing information on how DUPIXENT works, its cost and
coverage, accessing DUPIXENT, supplemental injection support, and more.
In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Patients in the DUPIXENT groups saw improved lung function in as little as 2 weeks.
Learn how DUPIXENT helped treat patients 12+ years old with their moderate-to-severe asthma.